A detailed history of Values First Advisors, Inc. transactions in Sage Therapeutics, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 27,947 shares of SAGE stock, worth $160,136. This represents 0.11% of its overall portfolio holdings.

Number of Shares
27,947
Previous 28,962 3.5%
Holding current value
$160,136
Previous $314,000 35.99%
% of portfolio
0.11%
Previous 0.19%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$7.02 - $13.08 $7,125 - $13,276
-1,015 Reduced 3.5%
27,947 $201,000
Q2 2024

Jul 19, 2024

BUY
$10.58 - $17.9 $117,289 - $198,439
11,086 Added 62.02%
28,962 $314,000
Q1 2024

Apr 23, 2024

BUY
$18.62 - $26.95 $16,683 - $24,147
896 Added 5.28%
17,876 $334,000
Q4 2023

Jan 18, 2024

BUY
$17.1 - $22.26 $108,653 - $141,440
6,354 Added 59.8%
16,980 $367,000
Q3 2023

Nov 08, 2023

BUY
$16.75 - $48.98 $177,985 - $520,461
10,626 New
10,626 $218,000
Q1 2023

May 15, 2023

BUY
$37.27 - $46.57 $37 - $46
1 New
1 $0
Q2 2020

Nov 15, 2022

SELL
$25.95 - $43.15 $110,105 - $183,085
-4,243 Closed
0 $0
Q1 2020

Jan 09, 2023

BUY
$26.15 - $77.24 $302,372 - $893,126
11,563 New
11,563 $332 Million
Q4 2019

Nov 15, 2022

BUY
$60.18 - $154.77 $255,343 - $656,689
4,243 New
4,243 $306,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.